2005 September 16 | Hiroshi Kurosu, Masaya Yamamoto, Jeremy D. Clark, Johanne V. Pastor, Animesh Nandi, Prem Gurnani, Owen P. McGuinness, Hirotaka Chikuda, Masayuki Yamaguchi, Hiroshi Kawaguchi, Ichiro Shimomura, Yoshiharu Takayama, Joachim Herz, C. Ronald Kahn, Kevin P. Rosenblatt, Makoto Kuro-o
The study investigates the role of the Klotho gene in aging and longevity. Klotho, originally identified in a mouse strain with age-dependent functional decline, encodes a transmembrane protein that is detectable in specific tissues. Overexpression of Klotho in mice extends their lifespan, suggesting that Klotho functions as an anti-aging hormone. The extracellular domain of Klotho protein circulates in the blood and binds to a cell-surface receptor, inhibiting insulin and IGF1 signaling. This inhibition leads to reduced activation of insulin and IGF1 receptors, decreased tyrosine phosphorylation of insulin receptor substrates, and reduced association with PI3-kinase. Klotho peptide, when injected into mice, increases blood glucose levels and reduces insulin sensitivity. Inhibiting insulin and IGF1 signaling in Klotho-deficient mice ameliorates age-related pathologies, including arteriosclerosis, ectopic calcification, skin atrophy, pulmonary emphysema, and hypogonadism. These findings suggest that Klotho-mediated inhibition of insulin and IGF1 signaling is a conserved mechanism for suppressing aging.The study investigates the role of the Klotho gene in aging and longevity. Klotho, originally identified in a mouse strain with age-dependent functional decline, encodes a transmembrane protein that is detectable in specific tissues. Overexpression of Klotho in mice extends their lifespan, suggesting that Klotho functions as an anti-aging hormone. The extracellular domain of Klotho protein circulates in the blood and binds to a cell-surface receptor, inhibiting insulin and IGF1 signaling. This inhibition leads to reduced activation of insulin and IGF1 receptors, decreased tyrosine phosphorylation of insulin receptor substrates, and reduced association with PI3-kinase. Klotho peptide, when injected into mice, increases blood glucose levels and reduces insulin sensitivity. Inhibiting insulin and IGF1 signaling in Klotho-deficient mice ameliorates age-related pathologies, including arteriosclerosis, ectopic calcification, skin atrophy, pulmonary emphysema, and hypogonadism. These findings suggest that Klotho-mediated inhibition of insulin and IGF1 signaling is a conserved mechanism for suppressing aging.